# CVS Health vs GSK: valuation, size and margins compared

URL: https://funkfolio.com/compare/cvs-vs-gsk

> CVS Health ($109.8B, P/E 10.3) and GSK ($98.7B, P/E 17.6) compared: size, valuation, margins, debt, cash and price change.

---

## CVS Health vs GSK

CVS Health (CVS), health care, and GSK (GSK), health care, side by side on market value, valuation, margins, balance sheet and price change. Higher and lower are marked; neither is called better.

CVS Health is worth $109.8B on the stock market and GSK $98.7B: CVS Health is valued at 11% more. CVS Health trades at 10.3 times earnings and GSK at 17.6; operating margins in their latest fiscal years were 1.16% and 24.3%. Over the past year CVS Health's share price has moved +13.7% and GSK's +6.42%.

### Key facts

- **CVS Health market value:** $109.8B
- **GSK market value:** $98.7B
- **CVS Health P/E:** 10.3
- **GSK P/E:** 17.6
- **CVS Health revenue:** $402.1B FY to 2025-12-31
- **GSK revenue:** $43.4B FY to 2025-12-31
- **Superinvestors holding both:** 6

Market values as of 18 Nov 2026, 04:52 UTC.

CVS Health vs GSK: every measure side by side

| Measure | CVS Health | GSK |
| --- | --- | --- |
| Sector | Health Care | Health Care |
| Country | United States | United Kingdom |
| Fiscal year ends | 2025-12-31 | 2025-12-31 |
| Size |  |  |
| Market cap | $109.8B higher | $98.7B lower |
| Revenue | $402.1B higher | $43.4B lower |
| Earnings | $1.8B lower | $7.6B higher |
| Employees | 219,000 higher | 66,841 lower |
| Total assets | $253.5B higher | $81.1B lower |
| Valuation |  |  |
| P/E | 10.3 lower | 17.6 higher |
| P/S | 0.3 lower | 2.3 higher |
| P/B | 1.4 | — |
| Dividend yield | 3.00% | — |
| Profitability |  |  |
| Operating margin | 1.16% lower | 24.3% higher |
| Balance sheet |  |  |
| Net assets | $75.2B higher | $21.7B lower |
| Total liabilities | $178.2B higher | $59.9B lower |
| Total debt | $64.6B higher | $19.2B lower |
| Cash on hand | $8.5B higher | $4.5B lower |
| Price change |  |  |
| Today | -3.14% lower | -2.32% higher |
| 1 year | +13.7% higher | +6.42% lower |

Market value, P/E, P/B, dividend yield and price changes are from live quotes (Yahoo Finance; prices may be delayed 15 minutes or more). Revenue, earnings, operating margin and the balance-sheet figures are from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day. P/S sets today's market value against the latest fiscal year's revenue. “Higher” and “lower” compare the two numbers only; a higher P/E or more debt is not better. Dividend yield and P/B are shown only for companies based in the US. A dash means no figure is on file.

### Share price over one year

Each company's share price rebased to 100 on Nov 17, 2025, so the two lines start together. Price only: dividends are not included. Last: CVS Health 109.4, GSK 103.6.

- CVS Health (CVS)
- GSK (GSK)

CVS Health and GSK share prices over one year, rebased to 100: CVS Health ends at 109.4, GSK at 103.6.

**The chart as a table**

Month-end share prices rebased to 100

| Month end | CVS | GSK |
| --- | --- | --- |
| Nov 28, 2025 | 102.5 | 100.7 |
| Dec 31, 2025 | 101.2 | 103.2 |
| Jan 30, 2026 | 95.0 | 108.6 |
| Feb 27, 2026 | 101.9 | 124.4 |
| Mar 31, 2026 | 91.6 | 116.1 |
| Apr 30, 2026 | 106.2 | 110.1 |
| May 29, 2026 | 116.0 | 106.3 |
| Jun 30, 2026 | 131.9 | 110.3 |
| Jul 31, 2026 | 133.2 | 108.8 |
| Aug 31, 2026 | 119.8 | 105.7 |
| Sep 30, 2026 | 109.3 | 101.3 |
| Oct 30, 2026 | 115.1 | 104.2 |
| Nov 17, 2026 | 109.4 | 103.6 |

### Which superinvestors hold them

From each tracked investor's latest 13F filing. A 13F lists long positions in US-listed shares at a quarter end, filed up to 45 days later.

#### Both (6)

- [Richard Pzena](https://funkfolio.com/gurus/richard-pzena) 2.6% / &lt;0.1%
- [Dodge & Cox team](https://funkfolio.com/gurus/dodge-and-cox) 2.1% / 1.1%
- [Charles Brandes (founder)](https://funkfolio.com/gurus/charles-brandes) 0.9% / 0.5%
- [Steve Cohen](https://funkfolio.com/gurus/steve-cohen) 0.3% / 0.2%
- [Primecap team](https://funkfolio.com/gurus/primecap) 0.1% / 0.8%
- [Jeremy Grantham (co-founder)](https://funkfolio.com/gurus/jeremy-grantham) 0.1% / 0.4%

#### CVS Health only (16)

- [Larry Robbins](https://funkfolio.com/gurus/larry-robbins) 10.0%
- [Prem Watsa](https://funkfolio.com/gurus/prem-watsa) 8.8%
- [Christopher Davis](https://funkfolio.com/gurus/christopher-davis) 4.4%
- [Samantha McLemore](https://funkfolio.com/gurus/samantha-mclemore) 2.8%
- [Andreas Halvorsen](https://funkfolio.com/gurus/andreas-halvorsen) 1.1%
- [Mark Boyar](https://funkfolio.com/gurus/mark-boyar) 0.8%
- [John Rogers](https://funkfolio.com/gurus/john-rogers) 0.7%
- [Brandon Haley](https://funkfolio.com/gurus/brandon-haley) 0.7%
- [Josef Lakonishok](https://funkfolio.com/gurus/josef-lakonishok) 0.7%
- [Rajiv Jain](https://funkfolio.com/gurus/rajiv-jain) 0.5%
- [Jim Simons (1938–2024)](https://funkfolio.com/gurus/jim-simons) 0.3%
- [Ken Griffin](https://funkfolio.com/gurus/ken-griffin) 0.3%
- [Ray Dalio (founder)](https://funkfolio.com/gurus/bridgewater) 0.2%
- [Paul Tudor Jones](https://funkfolio.com/gurus/paul-tudor-jones) 0.2%
- [Israel Englander](https://funkfolio.com/gurus/israel-englander) 0.2%
- [Bill Nygren](https://funkfolio.com/gurus/bill-nygren) &lt;0.1%

#### GSK only (5)

- [Thomas Kahn](https://funkfolio.com/gurus/thomas-kahn) 0.9%
- [Ken Fisher](https://funkfolio.com/gurus/ken-fisher) 0.5%
- [Tweedy, Browne team](https://funkfolio.com/gurus/tweedy-browne) 0.3%
- [Howard Gleicher](https://funkfolio.com/gurus/howard-gleicher) 0.1%
- [Murray Stahl](https://funkfolio.com/gurus/murray-stahl) &lt;0.1%

Percentages are each holding's share of that investor's reported portfolio (under "Both": CVS Health / GSK). [Who owns CVS](https://funkfolio.com/stock/CVS/superinvestors) · [Who owns GSK](https://funkfolio.com/stock/GSK/superinvestors)

### More on CVS Health

- [CVS Health (CVS) stock page](https://funkfolio.com/stock/CVS)
- [CVS Health market cap](https://funkfolio.com/stock/CVS/market-cap)
- [CVS Health revenue](https://funkfolio.com/stock/CVS/revenue)
- [CVS Health P/E ratio](https://funkfolio.com/stock/CVS/pe-ratio)
- [CVS Health operating margin](https://funkfolio.com/stock/CVS/operating-margin)
- [CVS Health total debt](https://funkfolio.com/stock/CVS/total-debt)
- [Largest health care companies](https://funkfolio.com/companies/sector/health-care)

### More on GSK

- [GSK (GSK) stock page](https://funkfolio.com/stock/GSK)
- [GSK market cap](https://funkfolio.com/stock/GSK/market-cap)
- [GSK revenue](https://funkfolio.com/stock/GSK/revenue)
- [GSK P/E ratio](https://funkfolio.com/stock/GSK/pe-ratio)
- [GSK operating margin](https://funkfolio.com/stock/GSK/operating-margin)
- [GSK total debt](https://funkfolio.com/stock/GSK/total-debt)
- [Largest health care companies](https://funkfolio.com/companies/sector/health-care)

### Further comparisons

#### CVS Health against its closest peers

- [CVS Health vs Moderna](https://funkfolio.com/compare/cvs-vs-mrna)
- [CVS Health vs HCA Healthcare](https://funkfolio.com/compare/cvs-vs-hca)
- [CVS Health vs Sanofi](https://funkfolio.com/compare/cvs-vs-sny)

#### GSK against its closest peers

- [GSK vs HCA Healthcare](https://funkfolio.com/compare/gsk-vs-hca)
- [GSK vs Moderna](https://funkfolio.com/compare/gsk-vs-mrna)
- [GSK vs Regeneron Pharmaceuticals](https://funkfolio.com/compare/gsk-vs-regn)

### Learn

- [What market capitalization is and is not](https://funkfolio.com/learn/markets/market-capitalization)
- [P/E ratio explained](https://funkfolio.com/learn/stocks/pe-ratio)
- [Market cap vs enterprise value](https://funkfolio.com/learn/markets/market-cap-vs-enterprise-value)

### Questions and answers

**Which is bigger, CVS Health or GSK?**

By market value, CVS Health is the larger: $109.8B against $98.7B for GSK. By revenue in its latest fiscal year, CVS Health is the larger: $402.1B against $43.4B for GSK.

**Which has the higher P/E ratio?**

GSK: 17.6, against 10.3 for CVS Health. A higher P/E means the market pays more for each dollar of the last twelve months' earnings; on its own it does not say which is the better value.

**Which has the higher operating margin?**

GSK: 24.3%, against 1.16% for CVS Health. Operating margin is operating income as a share of revenue in the latest fiscal year.

**Which has more debt?**

CVS Health: $64.6B, against $19.2B for GSK. Total debt is borrowings at the end of the latest fiscal year, as each company reported it; it is not set against cash here.

**Which superinvestors own both CVS Health and GSK?**

In their latest 13F filings, Richard Pzena, Dodge & Cox team, Charles Brandes (founder), Steve Cohen, Primecap team and Jeremy Grantham (co-founder) hold both.

### Cite this page

Funkfolio, “CVS Health vs GSK”, data as of 18 November 2026. https://funkfolio.com/compare/cvs-vs-gsk

Underlying data: Yahoo Finance quotes; SEC annual reports collected 2026-11-12; 13F filings.
